Fecal Transplantation: an Effective Remedy for Life-Threatening Intestinal Infections of C. difficile; While the Standard Treatment Is Often Insufficient to Treat Stubborn Bowel Disease, A Study Has Shown That More Than 90 Percent of Patients Were Completely Cured Using a New, Ground-Breaking Method

Feces transplantation in the intestine is an effective cure – and far superior to today’s standard treatment – for a life-threatening infection that affects between 2,500 and 3,000 people in Denmark every year. That is the conclusion of a new study conducted by researchers from Aarhus University and Aarhus University Hospital which has just been published in The Lancet Gastroenterology & Hepatology. In the study, the researchers examined the ground-breaking fecal transplantation treatment for patients infected with Clostridioides difficile (C. difficile), which typically affects elderly or vulnerable patients. The article is titled “Faecal Microbiota Transplantation for First or Second Clostridioides difficile infection (EarlyFMT): a Randomised, Double-Blind, Placebo-Controlled Trial.” The results of the study are extremely encouraging, says Simon Mark Dahl Baunwall (photo), a PhD student at the Department of Clinical Medicine and a doctor at Aarhus University Hospital. “Our new study shows that we can effectively cure the infection through the early use of fecal microbiota transplantation (FMT) after completing the standard treatment, to prevent relapses,” he says.